Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
Eurozone September consumer confidence (final) -16.5, in line with expected -16.5 and prior -16.5.
2026-09-29
Eurozone September consumer confidence (final) -16.5, in line with expected -16.5 and prior -16.5.
Back
Other News
2026-09-29
According to Israel's Channel 12: To date, the UK has suspended or refused to issue more than 80 export licenses to Israel for items that could be used by the Israel Defense Forces in Gaza. This number is almost three times the number of licenses res
According to Israel's Channel 12: To date, the UK has suspended or refused to issue more than 80 export licenses to Israel for items that could be used by the Israel Defense Forces in Gaza. This number is almost three times the number of licenses restricted when the government announced the restrictions in September 2024.
2026-09-29
Merck (MRK.N) said China's National Medical Products Administration (NMPA) approved a subcutaneous formulation of its PD‑1 inhibitor pembrolizumab for 19 solid‑tumor indications, making it the first and currently only PD‑1 inhibitor with an approved
Merck (MRK.N) said China's National Medical Products Administration (NMPA) approved a subcutaneous formulation of its PD‑1 inhibitor pembrolizumab for 19 solid‑tumor indications, making it the first and currently only PD‑1 inhibitor with an approved subcutaneous formulation in China.
Chat with us
, powered by
LiveChat